Corcept (CORT) Is a Great Choice for 'Trend' Investors, Here's Why

Core Viewpoint - The article emphasizes the importance of identifying sustainable trends in short-term investing, highlighting that while price momentum can be profitable, ensuring its longevity is crucial for success [1][2]. Group 1: Stock Performance - Corcept Therapeutics (CORT) has shown a solid price increase of 37.1% over the past 12 weeks, indicating strong investor interest [4]. - The stock has also increased by 11.8% in the last four weeks, suggesting that the upward trend is still intact [5]. - CORT is currently trading at 98.4% of its 52-week high-low range, indicating a potential breakout [5]. Group 2: Fundamental Strength - CORT holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises [6]. - The stock has an Average Broker Recommendation of 1 (Strong Buy), reflecting high optimism from the brokerage community regarding its near-term price performance [7]. - Historically, Zacks Rank 1 stocks have generated an average annual return of +25% since 1988, showcasing the effectiveness of this ranking system [7]. Group 3: Investment Strategy - The "Recent Price Strength" screen is a useful tool for identifying stocks with sufficient fundamental strength to maintain their upward momentum [3]. - In addition to CORT, there are other stocks that meet the criteria of the "Recent Price Strength" screen, suggesting further investment opportunities [8].